Egyptian Journal of Medical Human Genetics

Table 6 Association between the non-coding ANGPTL3 haplotype and the risk of CVD, CVA, AMI, CHD

From: Association of the ANGPTL3 gene polymorphisms and haplotypes with cardiovascular diseases in Birjand longitudinal aging study (BLAS)

Haplotype	OR (95%CI)
Haplotype	CVD	P	CVA	P	AMI	P	CHD	P
H1 (CAC)	0.6 (0.44–0.83)	0.002	0.6 (0.4–0.83)	0.002	0.6 (0. 4–0.8)	0.002	0.6 (0.4–0.8)	0.002
H2 (CAT)	1.47 (0.92–2.03)	0.1	1.4 (0.9–2.3)	0.1	1.4 (0.9–2.3)	0.1	1.47 (0.92–2.34)	0.1
H3 (GCC)	1.35 (0.83–2.21)	0.2	1.3 (0.8–2.2)	0.2	1.3 (0.8–2.2)	0.2	1.35 (0.83–2.2)	0.2
H4 (GCT)	1.15 (0.68–1.81)	0.66	1.1 (0.6–1.84)	0.6	1.15(0.68–1.8)	0.6	1.1 5 ((0.68–1.8)	0.6
H5 (GAC)	1.08 (0.51–2.3)	0.83	1.08 (0.5–2.3)	0.8	1.08 (0.5–2.3)	0.8	1.08 (0.5–2.3)	0.8
H6 (CCC)	2.55 (1.17–5.54)	0.014	2.5 (1.17–5.5)	0.01	2.5 (1.17–5.5)	0.01	2.5 (1.17–5.54)	0.01
H7 (GAT)	1.75 (1.03–2.98)	0.1	1.71 (1.03–2.09)	0.03	1.75 (1.03–2.98)	0.03	1.75 (1.03–2.9)	0.03
H8 (CCT)	0.45 (0.23–0.89)	0.02	0.4 (0.2–0.88)	0.02	0.4 (0.2–0.8)	0.02	0.45 (0.23–0.89)	0.02

Back to article page